Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microspherule protein 1 (MCRS1) is a nuclear RNA-binding protein involved in chromatin remodeling, mitotic spindle assembly, transcriptional regulation, and RNA metabolism. It stabilizes the minus ends of kinetochore fibers, ensuring proper spindle assembly during mitosis. As a part of several protein complexes, MCRS1 modulates transcription by interacting with transcriptional repressors (such as DAXX), participates in telomerase regulation, and binds various RNA structures. MCRS1 is associated with multiple biological processes including cell cycle progression and maintenance of chromosomal integrity. Altered expression or function of MCRS1 has been implicated in certain cancers and genetic disorders. There are currently no established drugs or therapies targeting MCRS1 directly, and its primary classification is as a chromatin-associated RNA-binding protein rather than a classical therapeutic target such as a receptor or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microspherule protein 1 (MCRS1).